🔎 Trials Near Me

Gara Jalqabaatti › Lymphoma › Tennessee › Nashville

Qorannoo klinikaalii Lymphoma Nashville, TN keessatti

Qorannoo 11 Lymphoma f Nashville fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma

Namoota walitti qabaa jiraSadarkaa 2
  • Sarah Cannon Research Institute Oncology Partners, Nashville
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT07015242

A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)

Namoota walitti qabaa jiraSadarkaa 2
  • SCRI Oncology Partners, Nashville
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Ful-2026 · NCT07221500

TLN-121 in Relapsed or Refractory Non-Hodgkin Lymphomas

Namoota walitti qabaa jiraSadarkaa 1
  • SCRI Oncology Partners, Nashville
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 04-Ful-2026 · NCT07082803

Study of Allo-QuadCAR01-T, an Allogeneic CAR-T Targeting CD19/CD20, in Patients With Relapsed or Refractory B-Cell Malignancies

Namoota walitti qabaa jiraSadarkaa 1/2
  • Sarah Cannon Research Institute, Nashville
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Hag-2026 · NCT07284433

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

Namoota walitti qabaa jiraSadarkaa 1/2
  • Vanderbilt University Medical Center, Nashville
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT05826535

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

Namoota walitti qabaa jiraSadarkaa 1/2
  • TriStar BMT, Nashville
Umuriin 13 hanga 90 · Saalaa hunda · Haaromfame 06-Hag-2026 · NCT06533579

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

Namoota walitti qabaa jiraSadarkaa 3
  • SCRI Oncology Partners, Nashville
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 04-Hag-2026 · NCT07188558

DALY II USA/ MB-CART2019.1 for DLBCL

Namoota walitti qabaa jiraSadarkaa 2
  • SCRI Oncology Partners, Nashville
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 13-Ado-2026 · NCT04792489

A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies

Namoota walitti qabaa jiraSadarkaa 1
  • Tennessee Oncology, Nashville
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 20-Bit-2026 · NCT04830137

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
  • Vanderbilt-Ingram Cancer Center, Nashville
Umuriin 40 fi ol · Saalaa hunda · Haaromfame 20-Ama-2026 · NCT05366881

HPC Offered for PRESERVE Expansion

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Tristar Centennial Medical Center, Nashville
Umuriin 12 hanga 80 · Saalaa hunda · Haaromfame 28-Hag-2025 · NCT07145411

Qorannoo Lymphoma magaalota biroo keessatti

Qorannoo biroo Nashville keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.